When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Jay Li doesn’t recommend getting sued by Tesla if you’re trying to get a startup off the ground. But he does think his company, Proception, might be better off for having endured the experience. “I think it’s kind of like a resilience test, or pressure test,” he told TechCrunch in an exclusive interview. “People say
Unlike AI gadgets like Rabbit or Humane, companies building dedicated gadgets for recording and transcribing meetings have actually seen some traction. The market is huge — though a bit constrained, as smartphones work fine for such tasks when paired with note-taking apps — and startups like Plaud, Mobvoi, Anker, Viaim, and Vibe have jumped in
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Jay Li doesn’t recommend getting sued by Tesla if you’re trying to get a startup off the ground. But he does think his company, Proception, might be better off for having endured the experience. “I think it’s kind of like a resilience test, or pressure test,” he told TechCrunch in an exclusive interview. “People say
Unlike AI gadgets like Rabbit or Humane, companies building dedicated gadgets for recording and transcribing meetings have actually seen some traction. The market is huge — though a bit constrained, as smartphones work fine for such tasks when paired with note-taking apps — and startups like Plaud, Mobvoi, Anker, Viaim, and Vibe have jumped in
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Jay Li doesn’t recommend getting sued by Tesla if you’re trying to get a startup off the ground. But he does think his company, Proception, might be better off for having endured the experience. “I think it’s kind of like a resilience test, or pressure test,” he told TechCrunch in an exclusive interview. “People say
Unlike AI gadgets like Rabbit or Humane, companies building dedicated gadgets for recording and transcribing meetings have actually seen some traction. The market is huge — though a bit constrained, as smartphones work fine for such tasks when paired with note-taking apps — and startups like Plaud, Mobvoi, Anker, Viaim, and Vibe have jumped in
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Jay Li doesn’t recommend getting sued by Tesla if you’re trying to get a startup off the ground. But he does think his company, Proception, might be better off for having endured the experience. “I think it’s kind of like a resilience test, or pressure test,” he told TechCrunch in an exclusive interview. “People say
Unlike AI gadgets like Rabbit or Humane, companies building dedicated gadgets for recording and transcribing meetings have actually seen some traction. The market is huge — though a bit constrained, as smartphones work fine for such tasks when paired with note-taking apps — and startups like Plaud, Mobvoi, Anker, Viaim, and Vibe have jumped in
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Jay Li doesn’t recommend getting sued by Tesla if you’re trying to get a startup off the ground. But he does think his company, Proception, might be better off for having endured the experience. “I think it’s kind of like a resilience test, or pressure test,” he told TechCrunch in an exclusive interview. “People say
Unlike AI gadgets like Rabbit or Humane, companies building dedicated gadgets for recording and transcribing meetings have actually seen some traction. The market is huge — though a bit constrained, as smartphones work fine for such tasks when paired with note-taking apps — and startups like Plaud, Mobvoi, Anker, Viaim, and Vibe have jumped in
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Jay Li doesn’t recommend getting sued by Tesla if you’re trying to get a startup off the ground. But he does think his company, Proception, might be better off for having endured the experience. “I think it’s kind of like a resilience test, or pressure test,” he told TechCrunch in an exclusive interview. “People say
Unlike AI gadgets like Rabbit or Humane, companies building dedicated gadgets for recording and transcribing meetings have actually seen some traction. The market is huge — though a bit constrained, as smartphones work fine for such tasks when paired with note-taking apps — and startups like Plaud, Mobvoi, Anker, Viaim, and Vibe have jumped in
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Jay Li doesn’t recommend getting sued by Tesla if you’re trying to get a startup off the ground. But he does think his company, Proception, might be better off for having endured the experience. “I think it’s kind of like a resilience test, or pressure test,” he told TechCrunch in an exclusive interview. “People say
Unlike AI gadgets like Rabbit or Humane, companies building dedicated gadgets for recording and transcribing meetings have actually seen some traction. The market is huge — though a bit constrained, as smartphones work fine for such tasks when paired with note-taking apps — and startups like Plaud, Mobvoi, Anker, Viaim, and Vibe have jumped in
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Jay Li doesn’t recommend getting sued by Tesla if you’re trying to get a startup off the ground. But he does think his company, Proception, might be better off for having endured the experience. “I think it’s kind of like a resilience test, or pressure test,” he told TechCrunch in an exclusive interview. “People say
Unlike AI gadgets like Rabbit or Humane, companies building dedicated gadgets for recording and transcribing meetings have actually seen some traction. The market is huge — though a bit constrained, as smartphones work fine for such tasks when paired with note-taking apps — and startups like Plaud, Mobvoi, Anker, Viaim, and Vibe have jumped in
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Jay Li doesn’t recommend getting sued by Tesla if you’re trying to get a startup off the ground. But he does think his company, Proception, might be better off for having endured the experience. “I think it’s kind of like a resilience test, or pressure test,” he told TechCrunch in an exclusive interview. “People say
Unlike AI gadgets like Rabbit or Humane, companies building dedicated gadgets for recording and transcribing meetings have actually seen some traction. The market is huge — though a bit constrained, as smartphones work fine for such tasks when paired with note-taking apps — and startups like Plaud, Mobvoi, Anker, Viaim, and Vibe have jumped in
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Jay Li doesn’t recommend getting sued by Tesla if you’re trying to get a startup off the ground. But he does think his company, Proception, might be better off for having endured the experience. “I think it’s kind of like a resilience test, or pressure test,” he told TechCrunch in an exclusive interview. “People say
Unlike AI gadgets like Rabbit or Humane, companies building dedicated gadgets for recording and transcribing meetings have actually seen some traction. The market is huge — though a bit constrained, as smartphones work fine for such tasks when paired with note-taking apps — and startups like Plaud, Mobvoi, Anker, Viaim, and Vibe have jumped in
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Jay Li doesn’t recommend getting sued by Tesla if you’re trying to get a startup off the ground. But he does think his company, Proception, might be better off for having endured the experience. “I think it’s kind of like a resilience test, or pressure test,” he told TechCrunch in an exclusive interview. “People say
Unlike AI gadgets like Rabbit or Humane, companies building dedicated gadgets for recording and transcribing meetings have actually seen some traction. The market is huge — though a bit constrained, as smartphones work fine for such tasks when paired with note-taking apps — and startups like Plaud, Mobvoi, Anker, Viaim, and Vibe have jumped in
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Jay Li doesn’t recommend getting sued by Tesla if you’re trying to get a startup off the ground. But he does think his company, Proception, might be better off for having endured the experience. “I think it’s kind of like a resilience test, or pressure test,” he told TechCrunch in an exclusive interview. “People say
Unlike AI gadgets like Rabbit or Humane, companies building dedicated gadgets for recording and transcribing meetings have actually seen some traction. The market is huge — though a bit constrained, as smartphones work fine for such tasks when paired with note-taking apps — and startups like Plaud, Mobvoi, Anker, Viaim, and Vibe have jumped in
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Jay Li doesn’t recommend getting sued by Tesla if you’re trying to get a startup off the ground. But he does think his company, Proception, might be better off for having endured the experience. “I think it’s kind of like a resilience test, or pressure test,” he told TechCrunch in an exclusive interview. “People say
Unlike AI gadgets like Rabbit or Humane, companies building dedicated gadgets for recording and transcribing meetings have actually seen some traction. The market is huge — though a bit constrained, as smartphones work fine for such tasks when paired with note-taking apps — and startups like Plaud, Mobvoi, Anker, Viaim, and Vibe have jumped in
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Jay Li doesn’t recommend getting sued by Tesla if you’re trying to get a startup off the ground. But he does think his company, Proception, might be better off for having endured the experience. “I think it’s kind of like a resilience test, or pressure test,” he told TechCrunch in an exclusive interview. “People say
Unlike AI gadgets like Rabbit or Humane, companies building dedicated gadgets for recording and transcribing meetings have actually seen some traction. The market is huge — though a bit constrained, as smartphones work fine for such tasks when paired with note-taking apps — and startups like Plaud, Mobvoi, Anker, Viaim, and Vibe have jumped in
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Jay Li doesn’t recommend getting sued by Tesla if you’re trying to get a startup off the ground. But he does think his company, Proception, might be better off for having endured the experience. “I think it’s kind of like a resilience test, or pressure test,” he told TechCrunch in an exclusive interview. “People say
Unlike AI gadgets like Rabbit or Humane, companies building dedicated gadgets for recording and transcribing meetings have actually seen some traction. The market is huge — though a bit constrained, as smartphones work fine for such tasks when paired with note-taking apps — and startups like Plaud, Mobvoi, Anker, Viaim, and Vibe have jumped in
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Jay Li doesn’t recommend getting sued by Tesla if you’re trying to get a startup off the ground. But he does think his company, Proception, might be better off for having endured the experience. “I think it’s kind of like a resilience test, or pressure test,” he told TechCrunch in an exclusive interview. “People say
Unlike AI gadgets like Rabbit or Humane, companies building dedicated gadgets for recording and transcribing meetings have actually seen some traction. The market is huge — though a bit constrained, as smartphones work fine for such tasks when paired with note-taking apps — and startups like Plaud, Mobvoi, Anker, Viaim, and Vibe have jumped in
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Jay Li doesn’t recommend getting sued by Tesla if you’re trying to get a startup off the ground. But he does think his company, Proception, might be better off for having endured the experience. “I think it’s kind of like a resilience test, or pressure test,” he told TechCrunch in an exclusive interview. “People say
Unlike AI gadgets like Rabbit or Humane, companies building dedicated gadgets for recording and transcribing meetings have actually seen some traction. The market is huge — though a bit constrained, as smartphones work fine for such tasks when paired with note-taking apps — and startups like Plaud, Mobvoi, Anker, Viaim, and Vibe have jumped in
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and
When AI agents begin working for people — and increasingly for one another — they will need a way to find jobs, pay for services, and build trust. Crypto exchange OKX is betting that future is closer than many expect, launching a marketplace where AI agents can hire one another, settle payments autonomously, and build
Jay Li doesn’t recommend getting sued by Tesla if you’re trying to get a startup off the ground. But he does think his company, Proception, might be better off for having endured the experience. “I think it’s kind of like a resilience test, or pressure test,” he told TechCrunch in an exclusive interview. “People say
Unlike AI gadgets like Rabbit or Humane, companies building dedicated gadgets for recording and transcribing meetings have actually seen some traction. The market is huge — though a bit constrained, as smartphones work fine for such tasks when paired with note-taking apps — and startups like Plaud, Mobvoi, Anker, Viaim, and Vibe have jumped in
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage of obesity drugs. Starting Wednesday, eligible beneficiaries can get GLP-1s to treat obesity for a copay of just $50 per month. It's a watershed move that could unlock a vast new patient population for Novo Nordisk and